#USA #New York #Investor Day #medical technology #Becton Dickinson

BD to Host Investor Day on December 10, 2026

BD (Becton, Dickinson and Company), recognized as a leader in the global medical technology field, has officially announced that it will hold its Investor Day on December 10, 2026. This event will take place in New York City, where a gathering of institutional investors and financial analysts is expected to explore the company's strategic initiatives and long-term outlook.

Event Details

The Investor Day is planned to kick off early in the morning, with registration starting at 7:30 AM ET. Attendees will hear from key executives, including Tom Polen, chairman and CEO, and Vitor Roque, executive vice president and CFO, who will outline BD's business strategy and capital deployment priorities. Following their presentations, there will be a question-and-answer session, providing investors the opportunity to engage directly with the leadership team.

Additionally, participants will have the unique chance to visit BD's Product Showcase, which will feature innovative products designed to support the company's growth objectives. The showcase opens at 7:30 AM ET and will remain available for exploration after the Q&A concludes.

Registration

To participate in the Investor Day, prior registration is necessary. Interested individuals should contact email protected] by December 3, 2026, to secure their spot, as space is limited. For those unable to attend in person, BD will also offer a live webcast of the presentations and Q&A session, accessible at [investors.bd.com. The agenda and additional resources will be made available prior to the event date.

About BD

BD is a pioneering medical technology company dedicated to advancing healthcare worldwide. With a commitment to innovation, BD operates with a purpose: advancing the world of health. The company specializes in areas such as medical essentials, connected care, and biopharmaceutical systems, with a broad mission to enhance patient outcomes. With more than 60,000 employees globally, BD is committed to developing transformative technologies and solutions that drive efficiency, safety, and access within the healthcare landscape.

BD is not just focused on immediate medical needs, but also works closely with healthcare professionals to create solutions that lower costs and improve clinical efficiency. Their annual production of billions of medical products impacts global healthcare positively, enhancing the overall operation of healthcare systems and elevating patient care.

To connect with BD for more insights, you can explore their website at bd.com or follow them on various social media platforms including LinkedIn, Twitter, and Instagram.

As BD gears up for this significant event, the excitement surrounding its plans and innovations continues to build, promising a day full of insights and future-forward discussions that could shape the landscape of medical technology for years to come.